Achillion Pharmaceuticals (ACHN)
Achillion Pharmaceuticals Historical Price Data
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 25, 2012 | 7.28 | 7.35 | 7.116 | 7.35 | 396210 |
| May 24, 2012 | 7.14 | 7.37 | 6.97 | 7.32 | 558056 |
| May 23, 2012 | 6.89 | 7.19 | 6.68 | 7.10 | 644507 |
| May 22, 2012 | 7.18 | 7.30 | 6.85 | 6.93 | 606327 |
| May 21, 2012 | 6.56 | 7.29 | 6.50 | 7.21 | 960299 |
| May 18, 2012 | 6.51 | 6.75 | 6.14 | 6.50 | 706275 |
| May 17, 2012 | 6.69 | 6.72 | 6.495 | 6.50 | 731561 |
| May 16, 2012 | 6.83 | 7.00 | 6.60 | 6.69 | 398585 |
| May 15, 2012 | 7.31 | 7.40 | 6.77 | 6.82 | 1285025 |
| May 14, 2012 | 7.11 | 7.18 | 6.88 | 6.89 | 391120 |
| May 11, 2012 | 6.75 | 7.32 | 6.68 | 7.20 | 761886 |
| May 10, 2012 | 6.49 | 6.96 | 6.421 | 6.80 | 1125218 |
| May 9, 2012 | 5.93 | 6.51 | 5.78 | 6.50 | 1122724 |
| May 8, 2012 | 5.96 | 6.06 | 5.83 | 6.05 | 579654 |
| May 7, 2012 | 6.07 | 6.184 | 5.90 | 5.99 | 620685 |
| May 4, 2012 | 6.44 | 6.468 | 5.96 | 5.99 | 752882 |
| May 3, 2012 | 6.55 | 6.58 | 6.31 | 6.43 | 565278 |
| May 2, 2012 | 6.52 | 6.71 | 6.50 | 6.59 | 435862 |
| May 1, 2012 | 6.67 | 6.77 | 6.59 | 6.60 | 527196 |
| April 30, 2012 | 6.86 | 6.86 | 6.62 | 6.65 | 730944 |
| April 27, 2012 | 6.83 | 7.08 | 6.640 | 6.90 | 693223 |
| April 26, 2012 | 6.86 | 6.95 | 6.60 | 6.79 | 989338 |
| April 24, 2012 | 6.77 | 7.14 | 6.56 | 6.97 | 1022585 |
| April 23, 2012 | 7.20 | 7.45 | 6.63 | 6.745 | 4860991 |
| April 20, 2012 | 8.31 | 8.40 | 8.09 | 8.28 | 796602 |
| April 19, 2012 | 7.63 | 8.40 | 7.16 | 8.30 | 6291904 |
| April 18, 2012 | 9.02 | 9.51 | 8.91 | 9.50 | 1082253 |
| April 17, 2012 | 8.88 | 9.44 | 8.88 | 9.05 | 897605 |
| April 16, 2012 | 9.12 | 9.15 | 8.57 | 8.77 | 920791 |
| April 13, 2012 | 9.59 | 9.61 | 9.01 | 9.02 | 846975 |
| April 12, 2012 | 10.13 | 10.21 | 9.59 | 9.64 | 920346 |
| April 11, 2012 | 10.57 | 10.68 | 10.04 | 10.15 | 544101 |
| April 10, 2012 | 10.59 | 10.73 | 10.29 | 10.36 | 1292135 |
| April 9, 2012 | 10.81 | 10.84 | 10.42 | 10.57 | 970407 |
| April 5, 2012 | 10.59 | 11.08 | 10.48 | 10.95 | 1639889 |
| April 4, 2012 | 10.36 | 10.58 | 10.15 | 10.47 | 1512510 |
| April 3, 2012 | 10.17 | 10.49 | 10.08 | 10.46 | 615366 |
| April 2, 2012 | 9.63 | 10.48 | 9.56 | 10.17 | 1338539 |
| March 30, 2012 | 10.05 | 10.05 | 9.56 | 9.58 | 478680 |
| March 29, 2012 | 9.66 | 10.03 | 9.44 | 9.96 | 885075 |
| March 28, 2012 | 10.21 | 10.44 | 9.55 | 9.73 | 696915 |
| March 27, 2012 | 10.25 | 10.33 | 10.08 | 10.09 | 659545 |
| March 26, 2012 | 10.02 | 10.44 | 9.95 | 10.22 | 547478 |
| March 23, 2012 | 9.96 | 10.08 | 9.76 | 9.92 | 389141 |
| March 22, 2012 | 10.42 | 10.52 | 9.855 | 9.93 | 677747 |
| March 21, 2012 | 9.94 | 9.94 | 9.94 | 9.94 | 0.00 |
| March 20, 2012 | 10.49 | 10.53 | 9.84 | 9.94 | 866446 |
| March 19, 2012 | 10.52 | 10.73 | 10.38 | 10.52 | 461988 |
| March 16, 2012 | 10.87 | 10.96 | 10.34 | 10.54 | 4108524 |
| March 15, 2012 | 10.70 | 11.15 | 10.59 | 10.80 | 1065267 |
ACHN News
$ACHN - http://stks.co/3yzI http://stks.co/3yzJ Updated chart. $7.40 trigger still intact.
about 2 days ago by Ammeo
about 2 days ago by Ammeo
$ACHN had a huge fall.....and has consolidated nicely. Should move up very well from here on its news. HF in here now too
about 6 days ago by taketheplunge
about 6 days ago by taketheplunge
News related to $ACHN, currently -5.6% since open: 'Achillion gets FDA incentives for hepatitis C drug' http://stks.co/3pmu
about 12 days ago by TradeBot
about 12 days ago by TradeBot
$ACHN up 7% in pre today but $IDIX still the better co. and both heating back up again lately while everyone distracted by $FB
about 12 days ago by QR_Winner
about 12 days ago by QR_Winner
EBR: Watchlist/worksheet/4 Trading Ideas: $OPTR $ACHN $BEAM $V http://stks.co/3pOI
about 12 days ago by TheEquitiesRoom
about 12 days ago by TheEquitiesRoom
ACH-3102 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C
May 15, 7:02AM Benzinga
May 15, 7:02AM Benzinga
@WalkenTalken nailed this $soda. For his next trick maybe he can endorse some $ACHN for me. Find out his take on $PCLN $MCP
about 18 days ago by HTB_Krull
about 18 days ago by HTB_Krull
Achillion Advances Second Generation Pan-Genotypic NS5A Inhibitor, ACH-3102, Into Clinical Development
May 09, 7:00AM GlobeNewswire
May 09, 7:00AM GlobeNewswire
$achn now green too......what is going on in hep c world? $achn $idix
about 19 days ago by taketheplunge
about 19 days ago by taketheplunge
UPDATE: UBS Investment Research Upgrades Achillion to Neutral; Balanced Risk/Reward
May 07, 12:55PM Benzinga
May 07, 12:55PM Benzinga
RT @AaronM @Bleedblue sorry about that confusion.. I heart $ARNA.. $ACHN blows < stop reading AF's columns and go long bud!>
about 26 days ago by Bleedblue
about 26 days ago by Bleedblue
Baird Maintains an 'Outperform' on Achillion Pharmaceuticals (ACHN); Reassuring Clarification on '1625
Apr 23, 2:22PM Street Insider
Apr 23, 2:22PM Street Insider
Wells Fargo Maintains an 'Outperform' on Achillion Pharmaceuticals (ACHN); A Few Hiccups, But Expect Positive N-T Data
Apr 23, 12:27PM Street Insider
Apr 23, 12:27PM Street Insider
Achillion (ACHN) Updates on EQT Data from Segment 2 of ACH-1625 Phase 2a
Apr 23, 9:27AM Street Insider
Apr 23, 9:27AM Street Insider
Pharmaceutical Companies Look to Biotech Industry to Combat Losses From Expiring Patents
Apr 23, 8:20AM Marketwire
Apr 23, 8:20AM Marketwire
JMP Securities Downgrades Achillion Pharmaceuticals (ACHN) to Market Perform
Apr 23, 8:08AM Street Insider
Apr 23, 8:08AM Street Insider
Achillion (ACHN) Presents Strong Data from ACH-1625 Phase 2a; Safety Profile Similar
Apr 23, 7:36AM Street Insider
Apr 23, 7:36AM Street Insider
Achillion Announces 94 - 100% Complete EVR From Phase 2 Trial With ACH-1625 Based Regimen in Hepatitis C
Apr 21, 4:00AM GlobeNewswire
Apr 21, 4:00AM GlobeNewswire
Baird Reiterates an 'Outperform' on Achillion Pharmaceuticals (ACHN); Buy on Weakness
Apr 19, 4:29PM Street Insider
Apr 19, 4:29PM Street Insider
UPDATE - UBS Initiates Coverage on Achillion Pharma (ACHN) with a Neutral; All-Oral Combo Already Priced In
Apr 12, 10:57AM Street Insider
Apr 12, 10:57AM Street Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ACHN | 7.35 | +0.03 | +0.41% | 518.69M |
| ABB | 16.18 | -0.22 | -1.34% | 37.45B |
| ABAX | 32.56 | -0.02 | -0.06% | 706.23M |
| AB | 13.38 | -0.19 | -1.40% | 1.407B |
| AAXJ | 49.90 | -0.38 | -0.76% | |
| AAWW | 45.92 | -0.76 | -1.63% | 1.208B |
| AAV | 2.83 | -0.01 | -0.35% | 471.39M |
| AAU | 2.01 | -0.04 | -1.95% | 118.83M |
| AAPL | 562.29 | -3.03 | -0.54% | 524.26B |
| AAP | 73.67 | +0.74 | +1.01% | 5.373B |